Product image of Amsparity (Adalimumab) supplied by GNH India

Amsparity

Active Ingredient:
Adalimumab
Origin:
EU

Amsparity (Adalimumab)

Amsparity (Adalimumab) is a subcutaneous medication used to manage inflammatory conditions. Learn about its uses, effects, and precautions for safe handling.

Manufacturer / TM Owner

Pfizer Europe Ma Eeig

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Amsparity (Adalimumab) is primarily used for the treatment of inflammatory conditions such as rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. This medication works by targeting specific proteins in the body that cause inflammation. Patients often ask, 'What is Amsparity used for?' It is commonly prescribed to reduce pain, swelling, and joint damage associated with these conditions.

Side Effects

  • Common effects of Amsparity (Adalimumab) may include injection site reactions, such as redness or swelling. Some users might experience mild to moderate side effects like headache, nausea, or fatigue. It is important to monitor for any unusual symptoms and consult a healthcare provider if they persist or worsen.

Precautions & Warnings

  • Amsparity (Adalimumab) should be handled with care. Store it at the recommended temperature and avoid freezing. Always follow the prescribed administration guidelines to minimize the risk of infection at the injection site. Inform your healthcare provider about any allergies or medical conditions before starting treatment.

Avoid Interactions

  • Amsparity (Adalimumab) may interact with other medications, including those that suppress the immune system. It is advisable to avoid alcohol while using this medication, as it can increase the risk of side effects. Always consult a healthcare provider before combining Amsparity with other treatments.

Frequently Asked Questions

Amsparity (Adalimumab) is used to manage inflammatory conditions like rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.

Amsparity is administered via subcutaneous injection, typically self-administered after proper training.

Common side effects include injection site reactions, headache, nausea, and fatigue.

Amsparity may interact with other medications, especially those that suppress the immune system. Consult a healthcare provider before combining treatments.

Amsparity should be stored at the recommended temperature and protected from freezing.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Adalimumab

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT